Compare TBLA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBLA | INDV |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 4.1B |
| IPO Year | N/A | N/A |
| Metric | TBLA | INDV |
|---|---|---|
| Price | $4.39 | $35.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $4.80 | ★ $32.50 |
| AVG Volume (30 Days) | 1.7M | ★ 3.4M |
| Earning Date | 11-05-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.08 | ★ 0.98 |
| Revenue | ★ $1,880,771,000.00 | $1,180,000,000.00 |
| Revenue This Year | $11.25 | $1.26 |
| Revenue Next Year | $5.55 | N/A |
| P/E Ratio | $56.86 | ★ $36.41 |
| Revenue Growth | ★ 10.96 | N/A |
| 52 Week Low | $2.50 | $7.62 |
| 52 Week High | $4.65 | $38.00 |
| Indicator | TBLA | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 60.58 | 58.92 |
| Support Level | $3.93 | $35.67 |
| Resistance Level | $4.65 | $36.55 |
| Average True Range (ATR) | 0.14 | 0.71 |
| MACD | 0.04 | -0.26 |
| Stochastic Oscillator | 66.68 | 44.44 |
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.